5Cook D. Ventialator associated pneumonia: perspectives on the burden of illness [J]. Intensive Care Meal, 2007, 26(11): 31-37.
6Ellis BL, Hirsch ML, Porter SN, et al. Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs [J]. University of Texas Southwestern Medical Center, 2011, 2(11): 1038-1048.
7Davit BM, Nwakama PE, Buehler GJ, et al. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration [J]. Center for Drug Evaluation and Research, 2009, 43(10):1583-1597.
8Ponto T, Ismail NI, Marmaya NH, et al. A prospective study on the pattern of medication use for schizophrenia in the outpatient pharmacy department [J]. Department of Clinical Pharmacy, 2010, 32(6): 427-443.
9Vollmcr WM, Xu M, Feldstein A, et al. Comparison of pharmacy-based measures of medication adherence[J]. BMC Health Serv Rcs, 2012, 12(1):155.
10Jenkins A, Eckel SF.Analyzing methods for improved management ofworkflow in an outpatient pharmacy setting [J]. Am J Health Syst Pharm, 2012, 69(11):966-971.
